(2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid

C53H74N8O18S2 — CID 155204906

IUPAC(2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid
SMILESC=C1CC(/C=N\OC)N(C(=O)c2cc(OC)c(OCCCCCOc3cc4c(cc3OC)C(=O)N3CC(=C)C[C@H]3C=N4)cc2NC(=O)OCC(C)SSC[C@@H](NC(=O)[C@H](CCC(=O)NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)NC)C(=O)O)C1
InChIInChI=1S/C53H74N8O18S2/c1-29-15-32-21-55-37-19-44(42(74-5)17-34(37)50(69)60(32)24-29)77-13-9-8-10-14-78-45-20-38(35(18-43(45)75-6)51(70)61-25-30(2)16-33(61)22-57-76-7)59-53(73)79-27-31(3)81-80-28-39(52(71)72)58-49(68)36(54-4)11-12-46(65)56-23-40(63)47(66)48(67)41(64)26-62/h17-22,31-33,36,39-41,47-48,54,62-64,66-67H,1-2,8-16,23-28H2,3-7H3,(H,56,65)(H,58,68)(H,59,73)(H,71,72)/b57-22-/t31?,32-,33?,36-,39+,40-,41+,47+,48+/m0/s1
InChIKeyAIQQFCLTOFRHCV-HTLAWIPCSA-N
MW1175.35 g/mol
LogP2.03
Rot. Bonds33

About (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid

(2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid (PubChem CID 155204906) has the molecular formula C53H74N8O18S2 and a molecular weight of 1175.35 g/mol. Its IUPAC name is (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid.

Molecular Properties

Compound Name(2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid
PubChem CID155204906
Molecular FormulaC53H74N8O18S2
Molecular Weight1175.35 g/mol
Exact Mass1174.46
IUPAC Name(2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid
SMILESC=C1CC(/C=N\OC)N(C(=O)c2cc(OC)c(OCCCCCOc3cc4c(cc3OC)C(=O)N3CC(=C)C[C@H]3C=N4)cc2NC(=O)OCC(C)SSC[C@@H](NC(=O)[C@H](CCC(=O)NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)NC)C(=O)O)C1
InChIInChI=1S/C53H74N8O18S2/c1-29-15-32-21-55-37-19-44(42(74-5)17-34(37)50(69)60(32)24-29)77-13-9-8-10-14-78-45-20-38(35(18-43(45)75-6)51(70)61-25-30(2)16-33(61)22-57-76-7)59-53(73)79-27-31(3)81-80-28-39(52(71)72)58-49(68)36(54-4)11-12-46(65)56-23-40(63)47(66)48(67)41(64)26-62/h17-22,31-33,36,39-41,47-48,54,62-64,66-67H,1-2,8-16,23-28H2,3-7H3,(H,56,65)(H,58,68)(H,59,73)(H,71,72)/b57-22-/t31?,32-,33?,36-,39+,40-,41+,47+,48+/m0/s1
InChIKeyAIQQFCLTOFRHCV-HTLAWIPCSA-N
XLogP2.03
TPSA358.50 Ų
H-Bond Donors10
H-Bond Acceptors22
Rotatable Bonds33
Heavy Atoms81
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001175.35
LogP ≤ 52.03
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid?
The IUPAC name of (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid (CID 155204906) is (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid.
What is the SMILES notation for (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid?
The canonical SMILES for (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid is C=C1CC(/C=N\OC)N(C(=O)c2cc(OC)c(OCCCCCOc3cc4c(cc3OC)C(=O)N3CC(=C)C[C@H]3C=N4)cc2NC(=O)OCC(C)SSC[C@@H](NC(=O)[C@H](CCC(=O)NC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)NC)C(=O)O)C1.
What is the InChIKey of (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid?
The InChIKey is AIQQFCLTOFRHCV-HTLAWIPCSA-N. The full InChI is InChI=1S/C53H74N8O18S2/c1-29-15-32-21-55-37-19-44(42(74-5)17-34(37)50(69)60(32)24-29)77-13-9-8-10-14-78-45-20-38(35(18-43(45)75-6)51(70)61-25-30(2)16-33(61)22-57-76-7)59-53(73)79-27-31(3)81-80-28-39(52(71)72)58-49(68)36(54-4)11-12-46(65)56-23-40(63)47(66)48(67)41(64)26-62/h17-22,31-33,36,39-41,47-48,54,62-64,66-67H,1-2,8-16,23-28H2,3-7H3,(H,56,65)(H,58,68)(H,59,73)(H,71,72)/b57-22-/t31?,32-,33?,36-,39+,40-,41+,47+,48+/m0/s1.
What are the key properties of (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid?
(2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid has a molecular weight of 1175.35 g/mol, XLogP of 2.03, 33 rotatable bonds, 10 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-3-[1-[[5-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-4-methoxy-2-[2-[(Z)-methoxyiminomethyl]-4-methylidenepyrrolidine-1-carbonyl]phenyl]carbamoyloxy]propan-2-yldisulfanyl]-2-[[(2S)-2-(methylamino)-5-oxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentanoyl]amino]propanoic acid is sourced from PubChem (CID 155204906), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).